El Awady, Mostafa K <br/><br/>
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  May 2011 
 - 843-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1746.2010.06605.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2',5'-Oligoadenylate Synthetase--genetics<br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Case-Control Studies<br/>Chi-Square Distribution<br/>DNA Mutational Analysis<br/>Drug Resistance, Viral<br/>Drug Therapy, Combination<br/>Egypt<br/>Exons<br/>Female<br/>Gene Frequency<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Liver Cirrhosis--genetics<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Phenotype<br/>Polyethylene Glycols--therapeutic use<br/>Polymorphism, Restriction Fragment Length<br/>Polymorphism, Single Nucleotide<br/>RNA Splice Sites<br/>Recombinant Proteins<br/>Ribavirin--therapeutic use<br/>Risk Assessment<br/>Risk Factors<br/>Treatment Outcome<br/>Young Adult